Pharmaceuticals Licensing and Reimbursement in the European Union, United States, and Japan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmaceuticals Licensing and Reimbursement in the European Union, United States, and Japan

Published:2016-10-17 Issue:6 Volume:100 Page:626-632
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Oye KA¹,Eichler HG²,Hoos A³,Mori Y⁴,Mullin TM⁵,Pearson M⁶

Affiliation:

1. Massachusetts Institute of Technology; Cambridge Massachusetts USA

2. European Medicines Agency; London UK

3. Amgen; Zug Switzerland

4. Ministry of Education, Culture, Sports, Science and Technology (MEXT); Tokyo Japan

5. U.S. Food and Drug Administration; Silver Spring Maryland USA

6. Organization for Economic Cooperation and Development; Paris France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference1 articles.

1. From adaptive licensing to adaptive pathways: Delivering a flexible life-span approach to bring new drugs to patients;Eichler;Clin. Pharmacol. Ther.,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time to market access in Italy: duration of the P&R process for rare disease drugs;Global and Regional Health Technology Assessment;2023-10-31

2. The timelines for the price and reimbursement authorization in Italy 2018–2020;Frontiers in Medicine;2022-12-21

3. Is regulatory innovation fit for purpose? A case study of adaptive regulation for advanced biotherapeutics;Regulation & Governance;2022-09-17

4. Acute radiation syndrome drug discovery using organ-on-chip platforms;Expert Opinion on Drug Discovery;2022-07-18

5. Health technology assessment processes: a North-South comparison of the evaluation and recommendation of health technologies in Canada and Chile;International Journal of Health Governance;2022-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3